HomeHealthCovid-19 update: India registers 63,509 cases, 730 deaths in 24-hour

Covid-19 update: India registers 63,509 cases, 730 deaths in 24-hour

India recorded 63,509 fresh cases of covid-19 in last 24-hour. The total case tally now stands at 72,39,390. With 730 fresh deaths, the fatality toll has soared high to 1,10,586.

Total case tally stands at 72,39,390 including 8,26,876 active cases, 63,01,928 cured/discharged/migrated cases and 1,10,586 deaths: Health Ministry.

The Centre on Tuesday informed that about 47 per cent of the death in the country have been among people aged below 60 years. This proves the latest study which denied age being susceptible to the virus.

The Centre also cautioned against any laxity towards taking precautions against the virus. It underlined that the virus may become even vulnerable in winter with respiratory diseases escalating.

Here’re more updates related to covid-19:

*The Indian Railways, on Tuesday, announced operation of 392 special trains during festival season. These trains will operate between October 20 and November 30.

*India’s average daily covid-19 positivity rate has witnessed a sharp decline in last four week and currently stands at 5.1 per cent.

*Kerala and Bengal have crossed the 3 lakh case mark on Tuesday even as total tally sees decline.

*At least three cases of reinfection have been recorded across the country, The Indian Council of Medical Research said.

*The results of phase three trials of the Oxford-AstraZeneca vaccine being conducted in India could be available by “end-November-early December”. The vaccine is being manufactured by Serum Institute of India.

*Facebook has banned anti-vaccination ads on its platform. The company already banned ads about vaccine “hoaxes,” which said vaccine can lead to autism

*India continues to report one of the lowest cases per million & lowest deaths per million in the world: ANI

*Cinema halls in Kolkata look forward to resume as per the covid-19 guidelines issued by the central government.

*US pharmaceutical firm, Eli Lilly, on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 due to safety reason.

Meanwhile, global Covid-19 cases have surpassed 38 million mark, according to the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University.

The global case tally on Tuesday stands at 38,006,121, with a total of 1,083,875 deaths worldwide, the CSSE data reported.

Enter Your Email To get daily Newsletter in your inbox

- Advertisement -

Latest Post

Latest News

- Advertisement -